Skip to main content
Erschienen in: Metabolic Brain Disease 3/2015

01.06.2015 | Research Article

GC-MS-based plasma metabolomic investigations of morphine dependent rats at different states of euphoria, tolerance and naloxone-precipitated withdrawal

verfasst von: Ruoxu Liu, Jianhua Cheng, Jingwen Yang, Xinghua Ding, Shuguang Yang, Fangting Dong, Ning Guo, Shaojun Liu

Erschienen in: Metabolic Brain Disease | Ausgabe 3/2015

Einloggen, um Zugang zu erhalten

Abstract

Long-term or excessive application of morphine leads to tolerance and addiction, which hindered its conventional applications as a drug. Although tremendous progress has been made on the mechanisms of morphine, crucial evidence elaborating the neurobiological basis of tolerance and dependence is still lacking. To further explore the physiological adaptions during morphine’s application, a systematic screening of small molecules in blood has been carried out. The plasma of morphine dependent rats was collected at different time points with or without naloxone treatment, and was analyzed by gas chromatography-mass spectrometry (GC-MS). Partial least squares discriminate analysis (PLS-DA) and the Student’s t Tests with the false discovery rate (FDR) correction were conducted on the normalized data for the distinction of groups and the identification of the most contributed metabolites. Clear separation is observed between different treatments, and 29 out of 41 metabolites changes significantly compared with the corresponding controls. The concentration of threonine, glycine, serine, beta-d-glucose and oxalic acid are consistently changed in all morphine treated groups compared with controls. Through this experiment we find characteristic metabolites in different dependent states and discuss the possible compensation effects. The interpretation of these metabolites would throw light on the biological effects of morphine and reveal the possibilities to become marker of morphine addiction.
Literatur
Zurück zum Zitat Arvelo MB, Cooper JT, Longo C, Daniel S, Grey ST, Mahiou J, Czismadia E, Abu-Jawdeh G, Ferran C (2002) A20 protects mice from D-galactosamine/lipopolysaccharide acute toxic lethal hepatitis. Hepatology 35(3):535–543. doi:10.1053/jhep.2002.31309 CrossRefPubMed Arvelo MB, Cooper JT, Longo C, Daniel S, Grey ST, Mahiou J, Czismadia E, Abu-Jawdeh G, Ferran C (2002) A20 protects mice from D-galactosamine/lipopolysaccharide acute toxic lethal hepatitis. Hepatology 35(3):535–543. doi:10.​1053/​jhep.​2002.​31309 CrossRefPubMed
Zurück zum Zitat Bagnol D, Mansour A, Akil H, Watson SJ (1997) Cellular localization and distribution of the cloned mu and kappa opioid receptors in rat gastrointestinal tract. Neuroscience 81(2):579–591CrossRefPubMed Bagnol D, Mansour A, Akil H, Watson SJ (1997) Cellular localization and distribution of the cloned mu and kappa opioid receptors in rat gastrointestinal tract. Neuroscience 81(2):579–591CrossRefPubMed
Zurück zum Zitat Bh HAR (2013) TOMES(R) information system, vol Volume 158. Micromedex, Inc, Englewood Bh HAR (2013) TOMES(R) information system, vol Volume 158. Micromedex, Inc, Englewood
Zurück zum Zitat Bryant HU, Bernton EW, Holaday JW (1987) Immunosuppressive effects of chronic morphine treatment in mice. Life Sci 41(14):1731–1738CrossRefPubMed Bryant HU, Bernton EW, Holaday JW (1987) Immunosuppressive effects of chronic morphine treatment in mice. Life Sci 41(14):1731–1738CrossRefPubMed
Zurück zum Zitat Buydens-Branchey L, Branchey M (2003) Association between low plasma levels of cholesterol and relapse in cocaine addicts. Psychosom Med 65(1):86–91CrossRefPubMed Buydens-Branchey L, Branchey M (2003) Association between low plasma levels of cholesterol and relapse in cocaine addicts. Psychosom Med 65(1):86–91CrossRefPubMed
Zurück zum Zitat Chen Y, Mestek A, Liu J, Hurley JA, Yu L (1993) Molecular cloning and functional expression of a mu-opioid receptor from rat brain. Mol Pharmacol 44(1):8–12PubMed Chen Y, Mestek A, Liu J, Hurley JA, Yu L (1993) Molecular cloning and functional expression of a mu-opioid receptor from rat brain. Mol Pharmacol 44(1):8–12PubMed
Zurück zum Zitat Evans CJ, Keith DE Jr, Morrison H, Magendzo K, Edwards RH (1992) Cloning of a delta opioid receptor by functional expression. Science 258(5090):1952–1955CrossRefPubMed Evans CJ, Keith DE Jr, Morrison H, Magendzo K, Edwards RH (1992) Cloning of a delta opioid receptor by functional expression. Science 258(5090):1952–1955CrossRefPubMed
Zurück zum Zitat Feng B, Wu S, Lv S, Liu F, Chen H, Yan X, Li Y, Dong F, Wei L (2007) Metabolic profiling analysis of a D-galactosamine/lipopolysaccharide-induced mouse model of fulminant hepatic failure. J Proteome Res 6(6):2161–2167. doi:10.1021/pr0606326 CrossRefPubMed Feng B, Wu S, Lv S, Liu F, Chen H, Yan X, Li Y, Dong F, Wei L (2007) Metabolic profiling analysis of a D-galactosamine/lipopolysaccharide-induced mouse model of fulminant hepatic failure. J Proteome Res 6(6):2161–2167. doi:10.​1021/​pr0606326 CrossRefPubMed
Zurück zum Zitat Feng B, Wu S, Lv S, Fang J, Liu F, Li Y, Gao Y, Yan X, Dong F, Wei L (2008) Dynamic metabonomic analysis of BALB/c mice with different outcomes after D-galactosamine/lipopolysaccharide-induced fulminant hepatic failure. Liver Transplant Off Publ Am Assoc Study Liver Dis Int Liver Transplant Soc 14(11):1620–1631. doi:10.1002/lt.21578 Feng B, Wu S, Lv S, Fang J, Liu F, Li Y, Gao Y, Yan X, Dong F, Wei L (2008) Dynamic metabonomic analysis of BALB/c mice with different outcomes after D-galactosamine/lipopolysaccharide-induced fulminant hepatic failure. Liver Transplant Off Publ Am Assoc Study Liver Dis Int Liver Transplant Soc 14(11):1620–1631. doi:10.​1002/​lt.​21578
Zurück zum Zitat Fiehn O, Kopka J, Dormann P, Altmann T, Trethewey RN, Willmitzer L (2000) Metabolite profiling for plant functional genomics. Nat Biotechnol 18(11):1157–1161. doi:10.1038/81137 CrossRefPubMed Fiehn O, Kopka J, Dormann P, Altmann T, Trethewey RN, Willmitzer L (2000) Metabolite profiling for plant functional genomics. Nat Biotechnol 18(11):1157–1161. doi:10.​1038/​81137 CrossRefPubMed
Zurück zum Zitat Francis DL, Schneider C (1971) Jumping after naloxone precipitated withdrawal of chronic morphine in the rat. Br J Pharmacol 41(2):424P–425PPubMedCentralPubMed Francis DL, Schneider C (1971) Jumping after naloxone precipitated withdrawal of chronic morphine in the rat. Br J Pharmacol 41(2):424P–425PPubMedCentralPubMed
Zurück zum Zitat Frenklakh L, Bhat RS, Bhaskaran M, Sharma S, Sharma M, Dinda A, Singhal PC (2006) Morphine-induced degradation of the host defense barrier role of intestinal mucosal injury. Dig Dis Sci 51(2):318–325. doi:10.1007/s10620-006-3132-0 CrossRefPubMed Frenklakh L, Bhat RS, Bhaskaran M, Sharma S, Sharma M, Dinda A, Singhal PC (2006) Morphine-induced degradation of the host defense barrier role of intestinal mucosal injury. Dig Dis Sci 51(2):318–325. doi:10.​1007/​s10620-006-3132-0 CrossRefPubMed
Zurück zum Zitat Hedner T, Cassuto J (1987) Opioids and opioid receptors in peripheral tissues. Scand J Gastroenterol Suppl 130:27–46CrossRefPubMed Hedner T, Cassuto J (1987) Opioids and opioid receptors in peripheral tissues. Scand J Gastroenterol Suppl 130:27–46CrossRefPubMed
Zurück zum Zitat Henderson G, McKnight AT (1997) The orphan opioid receptor and its endogenous ligand–nociceptin/orphanin FQ. Trends Pharmacol Sci 18(8):293–300CrossRefPubMed Henderson G, McKnight AT (1997) The orphan opioid receptor and its endogenous ligand–nociceptin/orphanin FQ. Trends Pharmacol Sci 18(8):293–300CrossRefPubMed
Zurück zum Zitat Kieffer BL, Befort K, Gaveriaux-Ruff C, Hirth CG (1992) The delta-opioid receptor: isolation of a cDNA by expression cloning and pharmacological characterization. Proc Natl Acad Sci U S A 89(24):12048–12052CrossRefPubMedCentralPubMed Kieffer BL, Befort K, Gaveriaux-Ruff C, Hirth CG (1992) The delta-opioid receptor: isolation of a cDNA by expression cloning and pharmacological characterization. Proc Natl Acad Sci U S A 89(24):12048–12052CrossRefPubMedCentralPubMed
Zurück zum Zitat Kleszczewska E, Wiszowata A, Lisowski P (2005) Determination of ascorbic and dehydroascorbic acid concentration using HPLC method in smokers with stable coronary artery disease scheduled for coronary artery bypass grafting (CABG). Przegl Lek 62(10):1054–1057PubMed Kleszczewska E, Wiszowata A, Lisowski P (2005) Determination of ascorbic and dehydroascorbic acid concentration using HPLC method in smokers with stable coronary artery disease scheduled for coronary artery bypass grafting (CABG). Przegl Lek 62(10):1054–1057PubMed
Zurück zum Zitat Kornetsky C, Wheeling HS (1982) An animal model for opiate induced euphoria and analgesia. Ther Umschau Rev Therapeutique 39(8):617–623 Kornetsky C, Wheeling HS (1982) An animal model for opiate induced euphoria and analgesia. Ther Umschau Rev Therapeutique 39(8):617–623
Zurück zum Zitat Lorenzetti OJ, Sancilio LF (1970) Morphine dependent rats as a model for evaluating potential addiction liability of analgesic compounds. Arch Int Pharmacodyn Ther 183(2):391–402PubMed Lorenzetti OJ, Sancilio LF (1970) Morphine dependent rats as a model for evaluating potential addiction liability of analgesic compounds. Arch Int Pharmacodyn Ther 183(2):391–402PubMed
Zurück zum Zitat Nishimura E, Buchan AM, McIntosh CH (1986) Autoradiographic localization of mu- and delta-type opioid receptors in the gastrointestinal tract of the rat and guinea pig. Gastroenterology 91(5):1084–1094PubMed Nishimura E, Buchan AM, McIntosh CH (1986) Autoradiographic localization of mu- and delta-type opioid receptors in the gastrointestinal tract of the rat and guinea pig. Gastroenterology 91(5):1084–1094PubMed
Zurück zum Zitat Olin M, Oh S, Roy S, Peterson P, Molitor T (2012) Morphine induces splenocyte trafficking into the CNS. J Neuroimmune Pharmacol Off J Soc NeuroImmune Pharmacol 7(2):436–443. doi:10.1007/s11481-011-9307-2 CrossRef Olin M, Oh S, Roy S, Peterson P, Molitor T (2012) Morphine induces splenocyte trafficking into the CNS. J Neuroimmune Pharmacol Off J Soc NeuroImmune Pharmacol 7(2):436–443. doi:10.​1007/​s11481-011-9307-2 CrossRef
Zurück zum Zitat Peng X, Cebra JJ, Adler MW, Meissler JJ Jr, Cowan A, Feng P, Eisenstein TK (2001) Morphine inhibits mucosal antibody responses and TGF-beta mRNA in gut-associated lymphoid tissue following oral cholera toxin in mice. J Immunol 167(7):3677–3681CrossRefPubMed Peng X, Cebra JJ, Adler MW, Meissler JJ Jr, Cowan A, Feng P, Eisenstein TK (2001) Morphine inhibits mucosal antibody responses and TGF-beta mRNA in gut-associated lymphoid tissue following oral cholera toxin in mice. J Immunol 167(7):3677–3681CrossRefPubMed
Zurück zum Zitat Sun B, Wu S, Li L, Li H, Zhang Q, Chen H, Li F, Dong F, Yan X (2009) A metabolomic analysis of the toxicity of Aconitum sp. alkaloids in rats using gas chromatography/mass spectrometry. Rapid Commun Mass Spect: RCM 23(8):1221–1228. doi:10.1002/rcm.3992 CrossRef Sun B, Wu S, Li L, Li H, Zhang Q, Chen H, Li F, Dong F, Yan X (2009) A metabolomic analysis of the toxicity of Aconitum sp. alkaloids in rats using gas chromatography/mass spectrometry. Rapid Commun Mass Spect: RCM 23(8):1221–1228. doi:10.​1002/​rcm.​3992 CrossRef
Zurück zum Zitat Thomson/Micromedex (2007) Drug information for the health care professional. vol Volume 1. Greenwood Village CO Thomson/Micromedex (2007) Drug information for the health care professional. vol Volume 1. Greenwood Village CO
Zurück zum Zitat Tubaro E, Avico U, Santiangeli C, Zuccaro P, Cavallo G, Pacifici R, Croce C, Borelli G (1985) Morphine and methadone impact on human phagocytic physiology. Int J Immunopharmacol 7(6):865–874CrossRefPubMed Tubaro E, Avico U, Santiangeli C, Zuccaro P, Cavallo G, Pacifici R, Croce C, Borelli G (1985) Morphine and methadone impact on human phagocytic physiology. Int J Immunopharmacol 7(6):865–874CrossRefPubMed
Zurück zum Zitat West JP, Lysle DT, Dykstra LA (1997) Tolerance development to morphine-induced alterations of immune status. Drug Alcohol Depend 46(3):147–157CrossRefPubMed West JP, Lysle DT, Dykstra LA (1997) Tolerance development to morphine-induced alterations of immune status. Drug Alcohol Depend 46(3):147–157CrossRefPubMed
Zurück zum Zitat Williams JT, Christie MJ, Manzoni O (2001) Cellular and synaptic adaptations mediating opioid dependence. Physiol Rev 81(1):299–343PubMed Williams JT, Christie MJ, Manzoni O (2001) Cellular and synaptic adaptations mediating opioid dependence. Physiol Rev 81(1):299–343PubMed
Zurück zum Zitat Wu H, Wacker D, Mileni M, Katritch V, Han GW, Vardy E, Liu W, Thompson AA, Huang XP, Carroll FI, Mascarella SW, Westkaemper RB, Mosier PD, Roth BL, Cherezov V, Stevens RC (2012) Structure of the human kappa-opioid receptor in complex with JDTic. Nature 485(7398):327–332. doi:10.1038/nature10939 CrossRefPubMedCentralPubMed Wu H, Wacker D, Mileni M, Katritch V, Han GW, Vardy E, Liu W, Thompson AA, Huang XP, Carroll FI, Mascarella SW, Westkaemper RB, Mosier PD, Roth BL, Cherezov V, Stevens RC (2012) Structure of the human kappa-opioid receptor in complex with JDTic. Nature 485(7398):327–332. doi:10.​1038/​nature10939 CrossRefPubMedCentralPubMed
Zurück zum Zitat Zhang J, Zhang Y (2008) Neuropharmacology. People’s Medical Publishing House Co., Beijing Zhang J, Zhang Y (2008) Neuropharmacology. People’s Medical Publishing House Co., Beijing
Zurück zum Zitat Zhu Y, Hsu MS, Pintar JE (1998) Developmental expression of the mu, kappa, and delta opioid receptor mRNAs in mouse. J Neurosci Off J Soc Neurosci 18(7):2538–2549 Zhu Y, Hsu MS, Pintar JE (1998) Developmental expression of the mu, kappa, and delta opioid receptor mRNAs in mouse. J Neurosci Off J Soc Neurosci 18(7):2538–2549
Metadaten
Titel
GC-MS-based plasma metabolomic investigations of morphine dependent rats at different states of euphoria, tolerance and naloxone-precipitated withdrawal
verfasst von
Ruoxu Liu
Jianhua Cheng
Jingwen Yang
Xinghua Ding
Shuguang Yang
Fangting Dong
Ning Guo
Shaojun Liu
Publikationsdatum
01.06.2015
Verlag
Springer US
Erschienen in
Metabolic Brain Disease / Ausgabe 3/2015
Print ISSN: 0885-7490
Elektronische ISSN: 1573-7365
DOI
https://doi.org/10.1007/s11011-014-9638-9

Weitere Artikel der Ausgabe 3/2015

Metabolic Brain Disease 3/2015 Zur Ausgabe

Leitlinien kompakt für die Neurologie

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Frühe Alzheimertherapie lohnt sich

25.04.2024 AAN-Jahrestagung 2024 Nachrichten

Ist die Tau-Last noch gering, scheint der Vorteil von Lecanemab besonders groß zu sein. Und beginnen Erkrankte verzögert mit der Behandlung, erreichen sie nicht mehr die kognitive Leistung wie bei einem früheren Start. Darauf deuten neue Analysen der Phase-3-Studie Clarity AD.

Viel Bewegung in der Parkinsonforschung

25.04.2024 Parkinson-Krankheit Nachrichten

Neue arznei- und zellbasierte Ansätze, Frühdiagnose mit Bewegungssensoren, Rückenmarkstimulation gegen Gehblockaden – in der Parkinsonforschung tut sich einiges. Auf dem Deutschen Parkinsonkongress ging es auch viel um technische Innovationen.

Demenzkranke durch Antipsychotika vielfach gefährdet

23.04.2024 Demenz Nachrichten

Wenn Demenzkranke aufgrund von Symptomen wie Agitation oder Aggressivität mit Antipsychotika behandelt werden, sind damit offenbar noch mehr Risiken verbunden als bislang angenommen.

Update Neurologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.